HomeMBX • NASDAQ
add
MBX Biosciences Inc
Previous close
$30.54
Day range
$29.98 - $32.07
Year range
$4.81 - $34.83
Market cap
1.44B USD
Avg Volume
843.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.93M | 22.00% |
Net income | -21.62M | -19.16% |
Net profit margin | — | — |
Earnings per share | -0.63 | 77.34% |
EBITDA | -23.88M | -22.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 391.67M | 41.37% |
Total assets | 400.08M | 41.67% |
Total liabilities | 12.54M | 13.65% |
Total equity | 387.54M | — |
Shares outstanding | 44.90M | — |
Price to book | 3.52 | — |
Return on assets | -18.94% | — |
Return on capital | -19.67% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -21.62M | -19.16% |
Cash from operations | -21.54M | -46.86% |
Cash from investing | 17.06M | 116.92% |
Cash from financing | 187.82M | -20.35% |
Net change in cash | 183.34M | 52.33% |
Free cash flow | -14.31M | -60.86% |
About
Founded
2018
Headquarters
Website
Employees
43
